Clarifying issues related to testing for drug use
Marcell, S.
American Journal of Hospital Pharmacy 46(2): 259-260
1989
ISSN/ISBN: 0002-9289 PMID: 2653025 Document Number: 338208
Document emailed within 1 workday
Related Documents
Ropelewski, L.R.; Hulbert, A.; Latimer, W.W. 2011: Factors related to past HIV testing among South African non-injection drug users Aids Care 23(11): 1519-1526Creel, A.H.; Rimal, R.N. 2011: Factors related to HIV-testing behavior and interest in testing in Namibia Aids Care 23(7): 901-907
Cone, E.J. 2006: Oral fluid testing: new technology enables drug testing without embarrassment Journal of the California Dental Association 34(4): 311-315
Mitarai, S. 2005: The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories Kekkaku: 80(4): 349-358
Thomas, J.W. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Liability issues Journal of the American Veterinary Medical Association 207(7): 899-900; Discussion: 902-904
Purandare, B. 2015: Successful Management of Highly Drug-Resistant Tuberculosis with Individualized Drug Susceptibility Testing Journal of the Association of Physicians of India 63(7): 94-95
Benner, P. 1982: Issues in competency-based testing Nursing Outlook 30(5): 303-309
De Silva, D. 2007: Emerging issues in genetic testing in Sri Lanka Indian Journal of Medical Ethics 4(3): 133-134
MacIntyre, N.R.; Foss, C.M. 2003: Pulmonary function testing: coding and billing issues Respiratory Care 48(8): 786-790
Cassel, C.K. 1998: Genetic testing and Alzheimer disease: ethical issues for providers and families Alzheimer Disease and Associated Disorders 12(Suppl 3): S16-S20
Weber, M.A.; Neutel, J.M.; Smith, D.H. 1995: Controlling blood pressure throughout the day: issues in testing a new anti-hypertensive agent Journal of Human Hypertension 9 Suppl. 5: S29-S35
Bergenstrom, A.; Sherr, L. 1999: HIV testing and prevention issues for women attending termination assessment clinics British Journal of Family Planning 25(1): 3-8
Bhatt, A.D. 1999: Drug-related problems and adverse drug events: negligence, litigation and prevention Journal of the Association of Physicians of India 47(7): 715-720
Lindahl, R.; Johnson, V.P. 1994: Molecular medicine: a primer for clinicians--Part VII: Ethical issues associated with genetic testing South Dakota Journal of Medicine 47(12): 415-419
Wojas, A.M.; Graham, A.S. 2009: Drug information services: the answer to your drug-related questions American Family Physician 80(7): 670
Lu, J.-m.; Wang, J.; Huang, X.-c.; Hu, Z.-y.; Cui, Z.-l. 2011: Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of mycobacterium tuberculosis in smear-positive sputum Zhonghua Yu Fang Yi Xue Za Zhi 45(1): 21-25
Sun, D.; Yu, L.X.; Hussain, M.A.; Wall, D.A.; Smith, R.L.; Amidon, G.L. 2004: In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome Current Opinion in Drug Discovery and Development 7(1): 75-85
White, M.T.; Callif-Daley, F.; Donnelly, J. 1999: Genetic testing for disease susceptibility: social, ethical and legal issues for family physicians American Family Physician 60(3): 748 750 755 757-8
1988: Critical issues in urinalysis of abused substances: report of the Substance-Abuse Testing Committee Clinical Chemistry 34(3): 605-632
Inoue, H.; Nata, M. 2010: Drug dependency and drug-related sudden death Nihon Rinsho. Japanese Journal of Clinical Medicine 68(8): 1560-1564